Bacteriophages show promise as antimicrobial agents

Slopek, 1983, Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results, Archivum Immunologi˦ae et Therapi˦ae Experimentalis, 31, 267 Tenover, 1996, The challenges of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens, JAMA, 275, 300, 10.1001/jama.275.4.300 Lonks, 1995, The growing threat of antibiotic-resistant Streptococcus pneumoniae, Med Clin N America, 79, 523, 10.1016/S0025-7125(16)30054-2 Murray, 1991, New aspects of antimicrobial resistance and the resulting therapeutic dilemmas, J Infect Dis, 163, 1184, 10.1093/infdis/163.6.1185 Hoffmann, 1995, The prevalence of drug-resistant streptococcus pneumoniae in Atlanta, N Engl J Med, 333, 481, 10.1056/NEJM199508243330803 Pallares, 1995, Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain, N Engl J Med, 333, 474, 10.1056/NEJM199508243330802 Berkowitz, 1995, Antibiotic resistance in bacteria, South Med J, 88, 797, 10.1097/00007611-199508000-00001 Jernigan, 1996, Minimizing the impact of drug-resistant streptococcus pneumoniae (DRSP): a strategy from the DRSP working group, JAMA, 275, 206, 10.1001/jama.275.3.206 Chopra, 1996, New approaches to the control of infections caused by antibiotic-resistant bacteria: an industry perspective, JAMA, 275, 401, 10.1001/jama.275.5.401 Plouffe, 1996, Bacteremia with streptococcus pneumonia: implications for therapy and prevention, JAMA, 275, 194, 10.1001/jama.275.3.194 Rahman, 1991, Antibacterial activity and inhibition of protein synthesis in Escherichia coli by antisense DNA analogs, Antisense Res Devel, 1, 319, 10.1089/ard.1991.1.319 Topley, 1929, The Principles of Bacteriology and Immunity, 224 Adams, 1959, Bacteriophages, 1 Brock, 1961, Milestones in Microbiology, 157 Raiga-Clemenceau, 1974, Le bacteriophage de d'Herelle et son pouvoir therapeutic, Semaine des Hopitaux Therapeutique, 50, 229 Dixon, 1987, Bacteriophage therapy, B M J Clinical Research Ed, 294, 1168 Kaczkowski, 1990, Zastosowanie bakteriofagow w leczeniu przewleklych chorob bakteryjnych, Wiadomosci Lekarskie, 43, 136 Slopek, 1983, Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results, Archivum Immunologi˦ et Therapi˦ Experimentalis, 31, 295 Slopek, 1984, Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases, Archivum Immunologi˦ et Therapi˦ Experimentalis, 32, 317 Slopek, 1985, Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases, Archivum Immunologi˦ et Therapi˦ae Experimentalis, 33, 219 Slopek, 1985, Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections, Archivum Immunologi˦ et Therapi˦ Experimentalis, 33, 241 Slopek, 1985, Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections, Archivum Immunologi˦ et Therapi˦ Experimentalis, 33, 261 Slopek, 1987, Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986, Archivum Immunologi˦ et Therapi˦ Experimentalis, 35, 569 Cislo, 1987, Bacteriophage treatment of suppurative skin infections, Archivum Immunologi˦ et Therapi˦ Experimentalis, 35, 175 Weber-Dabrowska, 1987, Studies on bacteriophage penetration in patients subjected to phage therapy, Archivum Immunologi˦ et Therapi˦ Experimentalis, 35, 563 Kucharewicz-Krukowska, 1987, Immunogenic effect of bacteriophage in patients subjected to phage therapy, Archivum Immunologi˦ et Therapi˦ Experimentalis, 35, 553 Chernomordik, 1989, Bakteriofagi i ikh lechebno-profilakticheskoe primenenie, Meditsinskaia Sestra, 48, 44 Sakandelidze, 1974, Primenenie kombinirovannykh fagov pri gniono-vospalitel'nykh zabolevaniiakh, Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii, 51, 135 Litvinova, 1979, K otsenkeeff ektivnosti primeneniia koli-proteinogo bakteriofaga pri dis'bakteriozakh kishechnika u novorozhdennykh nedonoshennykh detei, Voprosy Okhrany Materinstva i Detstva, 23, 42 Tolkacheva, 1981, Korrektsiia disbakterioza kishechnika biologicheskimi preparatami u bol'nykh ostrymi leikozami, Problemy Gematologii i Perelinavaniia Krovi, 26, 29 Samsygina, 1984, Bakteriofagi i fagoterapiia v pediatricheskoi praktike, Pediatriia, 4, 67 Kochetkova, 1989, Fagoterapiia posleoperatsionnykh gnoino-vospalite'lnykh oslozhnenii u onkologicheskikh bo'lnykh, Sovetskaia Meditsina, 6, 23 Sakandelidze, 1991, Kompleksnoe primenenie spetsificheskikh fagov i antibiotikov pri razlichnykh infektsionnykh allergozakh, Vrachebno Delo, 3, 60 Miliutina, 1993, Strategii i taktika etiotropnoi terapii ostrykh kishechnykh infektsii u detei na sovremennom etape, Antibiotiki i Khimioterapiia, 38, 46 Smith, 1982, Succesful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics, J Gen Micr, 128, 307 Smith, 1980, The association of the 018 K1 and H7 antigens and the CoIV plasmid of a strain of Escherichia coli with its virulence and immunogenicity, J Gen Micr, 121, 387 Smith, 1983, Effectiveness of phages in treating experimental Escherichia coli diarrhea in calves, piglets and lambs, J Gen Micr, 129, 2659 Smith, 1987, The control of experimental Escherichia coli diarrhea in calves by means of bacteriophages, J Gen Micr, 133, 1111 Smith, 1987, Factors influencing the survival and multiplication of bacteriophages in calves and in their environment, J Gen Micr, 133, 1127 Soothill, 1992, Treatment of experimental infections of mice with bacteriophages, J Med Micr, 37, 258, 10.1099/00222615-37-4-258 Soothill, 1994, Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa, Burns, 20, 209, 10.1016/0305-4179(94)90184-8 Geier, 1973, Fate of bacteriophage lambda in non-immune germ-free mice, Nature, 246, 221, 10.1038/246221a0 Merril, 1996, Long-circulating bacteriophage as antibacterial agents, 93, 3188 Kornstein, 1992, A natural mutant of plasmid RP4 that confers phage resistance and reduced conjugative transfer, FEMS Microbial Letters, 70, 97, 10.1111/j.1574-6968.1992.tb05191.x Biswas, 1992, A 14-kd inner membrane protein of Vibrio cholerae biotype el tor confers resistance to group IV choleraphage infection to classical vibrios, J Bact, 174, 6221, 10.1128/jb.174.19.6221-6229.1992 Balakshina, 1992, Dinamika vzaimodeistviia bakteriofaga phimF81 Pseudomonas aeruginosa s bakteriiami khoziiania, Mikrobiologica, 61, 1051 Coleman, 1989, Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of β-lysin staphylokinase and enterotoxin A: molecular mechanism of triple conversion, J Gen Micr, 135, 1679 Reidl, 1995, Characterization of Vibrio cholerae bacteriophage K139 and use of a novel mini-transposon to identify a phage-coded virulence factor, Molec Micr, 18, 685, 10.1111/j.1365-2958.1995.mmi_18040685.x Scotland, 1979, The occurrence of plasmids carrying genes for both enterotoxin production and drug resistance in Escherichia coli of human origin, J Hyg, 83, 531, 10.1017/S0022172400026383 Chausee, 1996, Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections, J Inf Dis, 173, 901, 10.1093/infdis/173.4.901 Kapur, 1992, Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes, Infect Immun, 60, 3513, 10.1128/IAI.60.9.3513-3517.1992 Zhou, 1993, Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain, Appl Environ Microbiol, 59, 3825, 10.1128/AEM.59.11.3825-3831.1993 Wachsmuth, 1983, Genetic transfer of antimicrobial resistance and enterotoxigenicity among Escherichia coli strains, Antimicrob Ag Chemother, 23, 278, 10.1128/AAC.23.2.278 Waldor, 1996, Lysogenic conversion by a filamentous phage encoding cholera toxin, Science, 272, 1910, 10.1126/science.272.5270.1910 Takeda, 1978, Bacteriophage conversions of heat-labile enterotoxins in Escherichia coli, J Bacteriol, 133, 278, 10.1128/JB.133.1.172-177.1978 Beutin, 1995, Virulence markers of Shiga-like toxin-producing Escherichia coli strains originating from healthy domestic animals of different species, J Clin Microbiol, 33, 631, 10.1128/JCM.33.3.631-635.1995 Muhldorfer, 1996, Regulation of the Shiga-like toxin II operon in Escherichia coli, Infect Immun, 64, 495, 10.1128/IAI.64.2.495-502.1996 Yee, 1993, Mitomycin-induced synthesis of a Shiga-like toxin from enteropathogenic Escherichia coli H.I.8, Infect Immun, 61, 4510, 10.1128/IAI.61.10.4510-4513.1993 Paton, 1992, Cloning and nucleotide sequence of a variant, 13, 225 Dickman, 1991, Soviet science: a struggle for survival, Science, 254, 1716, 10.1126/science.1763319 Aldhous, 1991, Hard times for Polish industrial researchers, Nature, 354, 341, 10.1038/354341a0 Kanin, 1991, Exodus likely to increase, Nature, 354, 342, 10.1038/354342b0